Attached files
| file | filename |
|---|---|
| 10-K - Hubei Minkang Pharmaceutical Ltd. | v228271_10k.htm |
| EX-32.1 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex32-1.htm |
| EX-99.4 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex99-4.htm |
| EX-99.7 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex99-7.htm |
| EX-99.1 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex99-1.htm |
| EX-99.2 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex99-2.htm |
| EX-99.3 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex99-3.htm |
| EX-31.1 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex31-1.htm |
| EX-99.6 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex99-6.htm |
| EX-99.5 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex99-5.htm |
| EX-31.2 - Hubei Minkang Pharmaceutical Ltd. | v228271_ex31-2.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K for fiscal year ended March 31, 2011 of Hubei Minkang Pharmaceutical Ltd., a Nevada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), I, Hsien Loong Wong, President, CEO, CFO, Secretary, Treasurer and a director of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
1.
|
The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
|
|
2.
|
The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Date: July 12, 2011
|
/s/ Hsien Loong Wong
|
|
|
Hsien Loong Wong, President, CEO, CFO, Secretary, Treasurer and Director (Principal Financial Officer)
|